RESPONSE TO THALIDOMIDE AND CYCLOSPORINE IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROME WITHOUT ISOLATED DEL(5Q)

被引:1
|
作者
Wang, J. [1 ]
Qin, T. [1 ]
Xu, Z. [1 ]
Zhang, Y. [1 ]
Gale, R. [2 ]
Fang, L. [1 ]
Zhang, H. [1 ]
Pan, L. [1 ]
Hu, N. [1 ]
Qu, S. [1 ]
Li, B. [1 ]
Xiao, Z. [1 ]
机构
[1] Inst Hematol & Blood Dis Hosp, MDS & MPN Ctr, Tianjin, Peoples R China
[2] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England
关键词
D O I
10.1016/S0145-2126(15)30256-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
255
引用
收藏
页码:S127 / S127
页数:1
相关论文
共 50 条
  • [31] A Novel Case of Myelodysplastic Syndrome With Isolated del(5q) and Concomitant CALR Mutation
    Ameri, Maryam Dadfarnia
    Chen, Chien-Shing
    Wang, Jun
    Rowsell, Edward
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A122 - A122
  • [32] Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide
    Lode, Laurence
    Menard, Audrey
    Flet, Laurent
    Richebourg, Steven
    Loirat, Marion
    Eveillard, Marion
    Le Bris, Yannick
    Godon, Catherine
    Theisen, Olivier
    Gagez, Anne-Laure
    Cartron, Guillaume
    Commes-Maerten, Therese
    Villemagne, Bruno
    Luycx, Odile
    Godmer, Pascal
    Pellat-Deceunynck, Catherine
    Soussi, Thierry
    Bene, Marie C.
    Delaunay, Jacques
    Peterlin, Pierre
    HAEMATOLOGICA, 2018, 103 (04) : E143 - E146
  • [33] What lies beyond del(5q) in myelodysplastic syndrome?
    Adema, Vera
    Bejar, Rafael
    HAEMATOLOGICA, 2013, 98 (12) : 1819 - 1821
  • [34] Increases In Mirna-145 and Mirna-146a Expression In Patients with IPSS Lower-Risk Myelodysplastic Syndromes and Del(5q) Treated with Lenalidomide
    Oliva, Esther Natalie
    Nobile, Francesco
    Iacopino, Pasquale
    Alimena, Giuliana
    Di Raimondo, Francesco
    Palumbo, Giuseppe A.
    Lagana, Carmelo
    D'Errigo, Maria Grazia
    Latagliata, Roberto
    Cuzzola, Maria
    BLOOD, 2010, 116 (21) : 1494 - 1494
  • [35] Clinical Outcomes, Survival, and Predictors in Lower-Risk Myelodysplastic Syndrome Patients Treated with Cyclosporine A
    Lu, Yingjia
    Zhang, Lina
    Qu, Weiying
    Feng, Zhou
    Deng, Yuan
    Zhao, Lin
    ACTA HAEMATOLOGICA, 2024, 147 (06) : 716 - 728
  • [36] Combination Therapy of Eltrombopag and Cyclosporine a Improves Hematopoiesis in Patients with Lower-Risk Myelodysplastic Syndrome
    Song, Luxi
    Chang, Chunkang
    Wang, Jianxiang
    BLOOD, 2022, 140 : 4084 - 4085
  • [37] Impact of Somatic Gene Mutations on Response to Lenalidomide (LEN) in IPSS Lower-Risk Myelodysplastic Syndromes (MDS) Patients (Pts) without Del(5q) and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents (ESAs)
    Santini, Valeria
    Fenaux, Pierre
    Giagounidis, Aristoteles
    Platzbecker, Uwe
    List, Alan F.
    Zhong, Jianhua
    Wu, Chengqing
    Mavrommatis, Konstantinos
    Beach, C. L.
    Hoenekopp, Albert
    MacBeth, Kyle J.
    BLOOD, 2016, 128 (22)
  • [38] RECURRENT MUTATIONS AS WELL AS CLONAL EVOLUTION ARE COMMON IN PATIENTS WITH LOWER-RISK MDS AND DEL(5Q) TREATED WITH LENALIDOMIDE
    Scharenberg, C.
    Karimi, M.
    Jansson, M.
    Walldin, G.
    Woll, P.
    Jacobsen, S. E.
    Hellstrom-Lindberg, E.
    LEUKEMIA RESEARCH, 2015, 39 : S84 - S84
  • [39] Images from the Haematologica Atlas of Hematologic Cytology: myelodysplastic syndrome with isolated del(5q)
    Invernizzi, Rosangela
    HAEMATOLOGICA, 2022, 107 (10) : 2285 - 2285
  • [40] Comparison of the Molecular Spectrum of Lenalidomide-Treated Myelodysplastic Syndrome with and without Del(5q)
    Adema, Vera
    Palomo, Laura
    Fuster-Tormo, Francisco
    Benito, Rocio
    Salgado, Rocio
    Such, Esperanza
    Kosmider, Olivier
    Larrayoz, Maria Jose
    Xicoy, Blanca
    Janusz, Kamila
    Maietta, Paolo
    Neef, Alexander
    Amunchastegui, Beatriz Arrizabalaga
    Fontenay, Michaela
    Gomez-Marzo, Paula
    Del Rey, Monica
    Ibanez, Mariam
    Haro, Nuri
    Mallo, Mar
    Zamora, Lurdes
    Visconte, Valeria
    Maciejewski, Jaroslaw P.
    Fenaux, Pierre
    Cervera, Jose
    Calasanz, Maria Jose
    Hernandez-Rivas, Jesus Maria
    Cigudosa, Juan
    Sole, Francesc
    BLOOD, 2016, 128 (22)